|
TBC1D15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.56780041674176E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.58070003939559E-09 |
| Normal-vs-Stage2 |
1.59619999999805E-05 |
| Normal-vs-Stage3 |
4.03199995613335E-09 |
| Normal-vs-Stage4 |
1.20960000016268E-07 |
| Stage1-vs-Stage2 |
8.833600E-01 |
| Stage1-vs-Stage3 |
4.258000E-01 |
| Stage1-vs-Stage4 |
3.632800E-01 |
| Stage2-vs-Stage3 |
6.837400E-01 |
| Stage2-vs-Stage4 |
5.527200E-01 |
| Stage3-vs-Stage4 |
7.658000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.75309997022077E-10 |
| Normal-vs-AfricanAmerican |
1.773910E-02 |
| Normal-vs-Asian |
4.73880000018134E-07 |
| Caucasian-vs-AfricanAmerican |
1.035580E-01 |
| Caucasian-vs-Asian |
7.943800E-01 |
| AfricanAmerican-vs-Asian |
1.207220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.97399932142662E-11 |
| Normal-vs-Female |
6.53020004737215E-09 |
| Male-vs-Female |
1.394610E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.09479999954587E-07 |
| Normal-vs-Age(41-60Yrs) |
1.77629999598139E-09 |
| Normal-vs-Age(61-80Yrs) |
1.84430000160773E-08 |
| Normal-vs-Age(81-100Yrs) |
3.084300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.757200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.244000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.763400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.020600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.765000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.301200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.480000E-01 |
| Classical-VS-Follicular |
4.356200E-01 |
| Classical-VS-Other |
1.021840E-01 |
| Classical-VS-Normal |
6.25670004694712E-09 |
| Tall-VS-Follicular |
7.523600E-01 |
| Tall-VS-Other |
2.107800E-01 |
| Tall-VS-Normal |
2.76779999996979E-06 |
| Follicular-VS-Other |
2.863400E-01 |
| Follicular-VS-Normal |
1.35519999999723E-06 |
| Other-VS-Normal |
3.020200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.80440029374074E-10 |
| Normal-vs-N1 |
6.53260000538225E-08 |
| N0-vs-N1 |
3.686000E-01 |
|
|
